Fluorescence readouts in HTS: no gain without pain?
被引:100
作者:
Gribbon, P
论文数: 0引用数: 0
h-index: 0
机构:
Pfizer Ltd, Global Res & Dev, Lead Discovery Technol, Sandwich CT13 9NJ, Kent, EnglandPfizer Ltd, Global Res & Dev, Lead Discovery Technol, Sandwich CT13 9NJ, Kent, England
Gribbon, P
[1
]
Sewing, A
论文数: 0引用数: 0
h-index: 0
机构:
Pfizer Ltd, Global Res & Dev, Lead Discovery Technol, Sandwich CT13 9NJ, Kent, EnglandPfizer Ltd, Global Res & Dev, Lead Discovery Technol, Sandwich CT13 9NJ, Kent, England
Sewing, A
[1
]
机构:
[1] Pfizer Ltd, Global Res & Dev, Lead Discovery Technol, Sandwich CT13 9NJ, Kent, England
Fluorescence-based detection technologies are frequently applied in biological testing, due to their unique advantages in setting up homogeneous, sensitive assays in miniaturized formats. However, the wide application of these readouts has highlighted challenges in reagent design and problems with interference from biological reagents and compounds. Here, we summarize the current application of fluorescence-based detection methodologies, focusing on the problems faced by assay developers and on solutions to reduce false positive and negative results in fluorescence-based HTS.